Sequana Medical

Kortrijksesteenweg 1112 bus 102

9051 Gent Sint-Denijs-Westrem

BE

Sequana Medical

Foundation date

22/09/2006

Sector

#Medical Technology

Subsector

Sequana Medical is a commercial stage medical device company focused on the development of innovative treatment solutions for fluid imbalance disorders in liver disease, cancer and heart failure. Its technology is based on the alfapump platform that moves excess fluid from the abdomen to the bladder. The alfapump is CE marked for liver refractory ascites and malignant ascites. The Company intends to expand into the US and is developing alfapump DSR for volume overload due to heart failure.

Upcoming events

Latest news

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023

  • Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

    Wednesday November 29th 2023

  • Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure

    Wednesday November 29th 2023